Circulating blood and platelets supply glycosyltransferases that enable extrinsic extracellular glycosylation

Glycobiology

Volumn 27, Issue 1, 2017, Pages 188-198

  Lee Sundlov, Melissa M ^a,c   Ashline, David J ^b   Hanneman, Andrew J ^b   Grozovsky, Renata ^c   Reinhold, Vernon N ^b   Hoffmeister, Karin M ^c   Lau, Joseph T Y ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEW HAMPSHIRE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Extrinsic glycosylation; Glycosyltransferases; Platelets; Serum

Indexed keywords

FUCOSYLTRANSFERASE; GALACTOSYLTRANSFERASE; GLYCAN; MONOMER; RADIOISOTOPE; SIALYL LEWIS X ANTIGEN; SIALYLTRANSFERASE; GLYCOSYLTRANSFERASE; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ARTICLE; CELL COMPARTMENTALIZATION; CHEMICAL STRUCTURE; ENZYME ACTIVITY; ENZYME ASSAY; GLYCOSYLATION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; TANDEM MASS SPECTROMETRY; THROMBOCYTE; THROMBOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMISTRY; ENZYMOLOGY; INFLAMMATION;

ANIMALS; BLOOD PLATELETS; FUCOSYLTRANSFERASES; GALACTOSYLTRANSFERASES; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMANS; INFLAMMATION; MICE; POLYSACCHARIDES; SIALYLTRANSFERASES;

EID: 85014436666     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cww108     Document Type: Article

References (61)

1. Appenheimer MM, Huang RY, Chandrasekaran EV, Dalziel M, Hu YP, Soloway PD, Wuensch SA, Matta KL, Lau JT. 2003. Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase. Glycobiology. 13:591-600.
2. Ashline D, Singh S, Hanneman A, Reinhold V. 2005. Congruent strategies for carbohydrate sequencing. 1. Mining structural details by MSn. Anal Chem. 77:6250-6262.
3. Ashline DJ, Hanneman AJ, Zhang H, Reinhold VN. 2014. Structural documentation of glycan epitopes: sequential mass spectrometry and spectral matching. J Am Soc Mass Spectrom. 25:444-453.
4. Beek WPV, Smets LA, Emmelot P. 1975. Changed surface glycoprotein as a marker of malignancy in human leukaemic cells. Nature. 253:457-460.
5. Boscher C, Dennis JW, Nabi IR. 2011. Glycosylation, galectins and cellular signaling. Curr Opin Cell Biol. 23:383-392.
6. Buergy D, Wenz F, Groden C, Brockmann MA. 2012. Tumor-platelet interaction in solid tumors. Int J Cancer. 130:2747-2760.
7. Buffone A Jr, Nasirikenari M, CT, Lugade A, Bogner PN, Sackstein R, Thanavala Y, Neelamegham S, Lau JT. 2016. Leukocyte-borne α (1, 3) - fucose is a negative regulator of β2-integrin-dependent recruitment in lung inflammation. J Leukoc Biol. pii: jlb.3A0516-215RR. [Epub ahead of print]. https://www.ncbi.nlm.nih.gov/pubmed/27566832.
8. Cazet A, Julien S, Bobowski M, Burchell J, Delannoy P. 2010. Tumourassociated carbohydrate antigens in breast cancer. Breast Cancer Res. 12:204-217.
9. Condac E, Dale GL, Bender-Neal D, Ferencz B, Towner R, Hinsdale ME. 2009. Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum. Glycobiology. 19:829-833.
10. Dall'Olio F. 2000. The sialyl-alpha2, 6-lactosaminyl-structure: biosynthesis and functional role. Glycoconj J. 17:669-676.
11. Dall'Olio F, Chiricolo M. 2001. Sialyltransferases in cancer. Glycoconj J. 18:841-850.
12. Dalziel M, Lemaire S, Ewing J, Kobayashi L, Lau JT. 1999. Hepatic acute phase induction of murine beta-galactoside alpha 2, 6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts. Glycobiology. 9:1003-1008.
13. Desantos-Garcia JL, Khalil SI, Hussein A, Hu Y, Mechref Y. 2011. Enhanced sensitivity of LC-MS analysis of permethylated N-glycans through online purification. Electrophoresis. 32:3516-3525.
14. Dimitroff CJ. 2015. Galectin-Binding O-Glycosylations as Regulators of Malignancy. Cancer Res. 75:3195-3202.
15. Chandrasekaran EV, Jain RK, Larsen RD, Wlasichuk K, Matta KL. 1995. Selectin ligands and tumor-associated carbohydrate structures: specificities of α.2, 3-sialyltransferases in the assembly of 3'-sialyl-6-sulfo/sialyl lewis a and x, 3'-sialyl-6'-sulfo lewis x, and 3'-sialyl-6-sialyl/sulfo blood group T-hapten. Biochemistry. 34:2925-2936.
16. Ellies LG, Ditto D, Levy GG, Wahrenbrock M, Ginsburg D, Varki A, Le DT, Marth JD. 2002. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci U S A. 99:10042-10047.
17. Foxall C, Watson SR, Dowbenko D, Fennie C, Lasky LA, Kiso M, Hasegawa A, Asa D, Brandley BK. 1992. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis (x) oligosaccharide. J Cell Biol. 117:895-902.
18. Garner OB, Baum LG. 2008. Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling. Biochem Soc Trans. 36:1472-1477.
19. Gracheva EV, Golovanova NK, Ezhov MV, Malyshev PP, Kukharchuk VV, Prokazova NV. 1999. Plasma sialyltransferase activity in healthy subjects and atherosclerotic patients. Biochemistry (Mosc). 64:1315-1319.
20. Hallmann R, Jutila MA, Smith CW, Anderson DC, Kishimoto TK, Butcher EC. 1991. The peripheral lymph node homing receptor, LECAM-1, is involved in CD18-independent adhesion of human neutrophils to endothelium. Biochem Biophys Res Commun. 174:236-243.
21. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi M-A, Samyn-Petit B, Julien S, Delannoy P. 2001. The human sialyltransferase family. Biochimie. 83:727-737.
22. Hoffmeister KM, Felbinger TW, Falet H, Denis CV, Bergmeier W, Mayadas TN, Andrian UHv, Wagner DD, Stossel TP, Hartwig JH. 2003. The clearance mechanism of chilled blood platelets. Cell. 112:87-97.
23. Holmes EH, Ostrander GK, Hakomori S. 1986. Biosynthesis of the sialyl-Lex determinant carried by type 2 chain glycosphingolipids (IV3NeuAcIII3 FucnLc4, VI3NeuAcV3FucnLc6, and VI3NeuAcIII3V3Fuc2nLc6) in human lung carcinoma PC9 cells. J Biol Chem. 261:3737-3743.
24. Hounsell EF, Young MIA, Davies MJ. 1997. Glycoprotein changes in tumours: a renaissance in clinical applications. Clin Sci. 93:287-293.
25. Ip C, Dao T. 1978. Alterations in serum glycosyltransferases and 5'-nucleotidase in breast cancer patients. Cancer Res. 38:723-728.
26. Jamieson JC, Lammers G, Janzen R, Woloski BMRNJ. 1987. The acute phase response to inflammation: the role of monokines in changes in liver glycoproteins and enzymes of glycoprotein metabolism. Comp Biochem Physiol. 87 b: 11-15.
27. Jamieson JC, McCaffrey G, Harder PG. 1993. Sialyltransferase: a novel acute-phase reactant. Comp Biochem Physiol B. 105:29-33.
28. Jones MB, Nasirikenari M, Feng L, Migliore MT, Choi KS, Kazim L, Lau JT. 2010. Role for hepatic and circulatory ST6Gal-1 sialyltransferase in regulating myelopoiesis. J Biol Chem. 285:25009-25017.
29. Jones MB, Oswald DM, Joshi S, Whiteheart SW, Orlando R, Cobb BA. 2016. B-cell-independent sialylation of IgG. Proc Natl Acad Sci U S A. 113:7207-7212.
30. Ju T, Otto VI, Cummings RD. 2011. The Tn antigen-structural simplicity and biological complexity. Angew Chem Int Ed. 50:1770-1791.
31. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. 2004. Carbohydratemediated cell adhesion in cancermetastasis and angiogenesis. Cancer Sci. 95:377-384.
32. Kaplan HA, Woloski BM, Hellman M, Jamieson JC. 1983. Studies on the effect of inflammation on rat liver and serum sialyltransferase. Evidence that inflammation causes release of Gal beta 1 leads to 4GlcNAc alpha 2 leads to 6 sialyltransferase from liver. J Biol Chem. 258:11505-11509.
33. Kim YS, Perdomo J, Whitehead JS, Curtis KJ. 1972. Glycosyltransferases in human blood: II. Study of serum galactosyltransferase and N-acetylgalactosaminyltransferase in patients with liver diseases. J Clin Invest. 8:2033-2039.
34. Kuhns WJ, Oliver RTD, Watkins WM, Greenwell P. 1980. Leukemia-induced alteration of serum glycoslytransferase enzymes. Cancer Res. 40:268-275.
35. Lammers G, Jamieson JC. 1986. Studies on the effect of experimental inflammation on sialyltransferase in the mouse and guinea pig. Comp Biochem Physiol B. 84:181-187.
36. Lee MM, Nasirikenari M, Manhardt CT, Ashline DJ, Hanneman AJ, Reinhold VN, Lau JT. 2014. Platelets support extracellular sialylation by supplying the sugar donor substrate. J Biol Chem. 289:8742-8748.
37. Li Z, Rumbaut RE, Burns AR, Smith CW. 2006. Platelet response to corneal abrasion is necessary for acute inflammation and efficient reepithelialization. Invest Ophthalmol Vis Sci. 47:4794-4802.
38. Nasirikenari M, Chandrasekaran EV, Matta KL, Segal BH, Bogner PN, Lugade AA, Thanavala Y, Lee JJ, Lau JT. 2010. Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation. J Leukoc Biol. 87:457-466.
39. Nasirikenari M, Segal BH, Ostberg JR, Urbasic A, Lau JT. 2006. Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I. Blood. 108:3397-3405.
40. Nasirikenari M, Veillon L, Collins CC, Azadi P, Lau JT. 2014. Remodeling of marrow hematopoietic stem and progenitor cells by non-self ST6Gal-1 sialyltransferase. J Biol Chem. 289:7178-7189.
41. Priatel JJ, Chui D, Hiraoka N, Simmons CJ, Richardson KB, Page DM, Fukuda M, Varki NM, Marth JD. 2000. The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity. 12:273-283.
42. Reddi AS, Oppermann W, Reddy MP, Velasco CA, Camerini-Davalos RA. 1976. Elevated kidney glucosyltransferase activity in genetic prediabetic mice. Experientia. 32:1237-1238.
43. Rumjantseva V, Grewal PK, Wandall HH, Josefsson EC, Sorensen AL, Larson G, Marth JD, Hartwig JH, Hoffmeister KM. 2009. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med. 15:1273-1280.
44. Semel AC, Seales EC, Singhal A, Eklund EA, Colley KJ, Bellis SL. 2002. Hyposialylation of integrins stimulates the activity of myeloid fibronectin receptors. J Biol Chem. 277:32830-32836.
45. Silva M, Silva Z, Marques G, Ferro T, Gonçalves M, Monteiro M, van Vliet SJ, Mohr E, Lino AC, Fernandes AR, et al. 2016. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts antitumor immune responses. Oncotarget. 7:41053-41066.
46. Sorensen AL, Rumjantseva V, Nayeb-Hashemi S, Clausen H, Hartwig JH, Wandall HH, Hoffmeister KM. 2009. Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes. Blood. 114:1645-1654.
47. Sperandio M, Gleissner CA, Ley K. 2009. Glycosylation in immune cell trafficking. Immunol Rev. 230:97-113.
48. Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot CV, Coward J, et al. 2012. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 366:610-618.
49. Teixidó J, Hemler ME, Greenberger JS, Anklesaria P. 1992. Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. J Clin Invest. 90:358-367.
50. Thijssen VL, Heusschen R, Caers J, Griffioen AW. 2015. Galectin expression in cancer diagnosis and prognosis: a systematic review. Biochimica et biophysica acta. Biochim Biophys Acta. 1855:235-247.
51. Tiedt R, Schomber T, Hao-Shen H, Skoda RC. 2007. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood. 109:1503-1506.
52. Ujita M, McAuliffe J, Schwientek T, Almeida R, Hindsgaul O, Clausen H, Fukuda M. 1998. Synthesis of poly-N-acetyllactosamine in core 2 branched O-glycans. The requirement of novel beta-1, 4-galactosyltransferase IV and beta-1, 3-n-acetylglucosaminyltransferase. J Biol Chem. 273:34843-34849.
53. van der Harst P, Zhang W, Mateo Leach I, Rendon A, Verweij N, Sehmi J, Paul DS, Elling U, Allayee H, Li X, et al. 2012. Seventy-five genetic loci influencing the human red blood cell. Nature. 492:369-375.
54. van Dijk W, Boers W, Sala M, Lasthuis AM, Mookerjea S. 1986. Activity and secretion of sialyltransferase in primary monolayer cultures of rat hepatocytes cultured with and without dexamethasone. Biochem Cell Biol. 64:79-84.
55. Varki A, Angata T. 2006. Siglecs-the major subfamily of I-type lectins. Glycobiology. 16:1R-27R.
56. Wandall HH, Rumjantseva V, Sorensen AL, Patel-Hett S, Josefsson EC, Bennett EP, Italiano JE Jr, Clausen H, Hartwig JH, Hoffmeister KM. 2012. The origin and function of platelet glycosyltransferases. Blood. 120:626-635.
57. Wang XC, O'Hanlon TP, Lau JT. 1989. Regulation of beta-galactoside alpha 2, 6-sialyltransferase gene expression by dexamethasone. J Biol Chem. 264:1854-1859.
58. Wang XC, Smith TJ, Lau JT. 1990. Transcriptional regulation of the liver beta-galactoside alpha 2, 6-sialyltransferase by glucocorticoids. J Biol Chem. 265:17849-17853.
59. Weiser MM, Podolsky DK, Iselbacher KJ. 1976. Cancer-associated isoenzyme of serum galactosyltransferase. Proc Natl Acad Sci USA. 73:1319-1322.
60. Woloski BMRNJ, Gospodarek E, Jamieson JC. 1985. Studies on monokines as mediators of acute phase response: effects on sialyltransferases, albumin, alpha-1-acid glycoprotein and -N-acetylhexosaminidase. Biochem Biophys Res Commun. 130:30-36.
61. Yuan L, Xishi L. 2015. Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesisdependent mechanism. Mol Med Rep. 11:2449-2458.